Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-14

Clinical Trial Update: The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update on prolonged pramlintide infusion in pediatric Type 1 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • pramlintide (pramlintide)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED